Results 71 to 80 of about 10,309 (223)

Fucosylation limits ADCC in clinically used anti‐RhD monoclonal antibodies

open access: yesTransfusion, EarlyView.
Abstract Background Haemolytic disease of the fetus and newborn (HDFN) is caused by maternal alloantibodies, often targeting the D antigen on fetal red blood cells. Maternal immunization is preventable with timely administration of anti‐D polyclonal antibodies (pAbs).
Gabriela Koike   +33 more
wiley   +1 more source

Molecular studies reveal a concordant KEL genotyping between patients with hemoglobinopathies and blood donors in São Paulo City, Brazil [PDF]

open access: yes, 2008
Universidade Federal de São Paulo, Discipline Hematol & Transfus Med, BR-04023092 São Paulo, BrazilUniversidade Federal de São Paulo, Discipline Hematol & Transfus Med, BR-04023092 São Paulo, BrazilWeb of ...
Bordin, Jose Orlando   +4 more
core   +1 more source

Platelet Biochemistry and Morphology after Cryopreservation [PDF]

open access: yes, 2020
Platelet cryopreservation has been investigated for several decades as an alternative to room temperature storage of platelet concentrates. The use of dimethylsulfoxide as a cryoprotectant has improved platelet storage and cryopreserved concentrates can ...
Compernolle, Veerle   +2 more
core   +1 more source

Re-Evaluation Of Modified Rapid Monoclonal Antibody Immobilization Of Platelet Antigen (MR-MAIPA) For Detecting Platelet Antibody In Patients With Suspected Immune Thrombocytopenia [PDF]

open access: yes, 2016
Ujian antibodi terhadap platelet di Malaysia hanya dijalankan di Pusat Darah Negara (PDN), Kuala Lumpur. Sebelum tahun 2013, ujian antibodi terhadap platelet di Malaysia dijalankan menggunakan teknik MAIPA. Namun begitu, MAIPA memerlukan masa selama tiga
Aziz, Mohd Fahmi
core  

Early exposure, enduring consequences: How do I manage Rh immunoglobulin prophylaxis after Rh‐mismatched transfusions in children?

open access: yesTransfusion, EarlyView.
Abstract Background RhD mismatched transfusions in RhD negative women have the potential to impact future pregnancies through alloimmunization and development of hemolytic disease of the fetus and newborn (HDFN). As use of RhD positive emergency‐release blood products in pediatric trauma has increased, it has become clear that a significant ...
Kirea Lange   +7 more
wiley   +1 more source

Prenatal treatment of severe fetal hemolytic disease due to anti-M alloimmunization by serial intrauterine transfusions

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2017
Objective: Fetal hemolytic disease is a common cause of fetal hydrops and fetal morbidity and mortality. Despite its relatively low frequency, the anti-M IgG antibody is one of the causes of severe fetal anemia and intrauterine death; only a few cases ...
Lin Li   +4 more
doaj   +1 more source

بررسی آلوايميونيزاسيون در بيماران مولتی ترانس فيوز (تالاسمی) مراجعه‌کننده به بيمارستان حضرت علی اصغر(ع) تهران در سال 84-1383 [PDF]

open access: yes, 2009
زمينه و هدف: بيماران تالاسمی به علت ماهيت بيماری نياز به تزريق خون مداوم دارند. بيمارانی که به‌طور مکرر خون می‌زنند، می‌توانند به مرور زمان آنتی‌بادی عليه زيرگروه‌های فرعی خون به‌وجود آورند.
آذرکيوان, آزیتا   +3 more
core  

Neonatal Alloimmune Thrombocytopenia

open access: yesClinics in Laboratory Medicine, 1992
Neonatal alloimmune thrombocytopenia is caused by the transplacental passage of maternal antibodies directed against platelet-specific antigens. Because complications from bleeding may result, prompt institution of therapy may be necessary. Accurate diagnosis by serologic techniques permits appropriate therapy to be administered both prenatally and ...
openaire   +2 more sources

Alloimmun Sitopeniler

open access: yesÇocuk Dergisi / Journal of Child, 2021
Immune cytopenias occur as a result of the destruction of erythrocytes, platelets, and neutrophils or more than one cell line at the same time through the immune system stimulated by autoantibodies or alloantibodies. Alloantibodies are formed when the organism is stimulated when it encounters antigens of the same type, called alloantigen or isoantigen,
openaire   +3 more sources

Home - About - Disclaimer - Privacy